In the realm of Clinical Research, Next Generation Sequencing (NGS) projects hold the key to unlocking profound insights into biological processes and discovering new biomarkers. But how do you get from raw data to actionable insights? The critical step is data analysis, and too often, scientists find themselves waiting for this crucial phase to be completed.
Are you tired of delays in your sequencing data analysis?
At IQVIA Laboratories Bioinformatics, we understand the urgency of your research. That's why we offer a comprehensive suite of analysis pipelines and customizable solutions designed to expedite your journey from data to discovery. By breaking through the bottlenecks of data analysis, we empower sponsor teams to focus on what matters most: uncovering new insights.
Why choose IQVIA Laboratories Bioinformatics?
Our track record speaks for itself. With over 100,000 samples analyzed across all regulatory tiers and regions, our harmonized infrastructure ensures consistency and reliability in your results—whether you're operating in the US, China, or anywhere else globally.
Do standard pipelines not fit your needs? We’ve got you covered. We can customize new pipelines for your specific analysis requirements or even integrate your existing pipeline into our environment for seamless and efficient processing.
Ready to accelerate your research and achieve global harmonization?
Discover how IQVIA Laboratories Bioinformatics can transform your NGS data analysis experience.
Start your journey today. Complete the form below to access this insight brief.
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
